Sightera Biosciences SRL
Sightera Biosciences reported total assets of 63,382 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 May 2026).
The score of Sightera Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sightera Biosciences's annual accounts
| 2025 | |
|---|---|
| Net result | 41,452 € |
| Equity | 47,452 € |
| Cash | 42,658 € |
| EBITDA | 41,679 € |
| Total assets | 63,382 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 May 2026
Sightera Biosciences's financial analysis
- Solvency74.9%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sightera Biosciences
10 active director(s) in the register.
and 4 more
Sightera Biosciences's shareholders and holdings →Sightera Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1018.457.141
- VAT number
- BE1018457141
- Peppol
- Registered · 0208:1018457141 · as of 12 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jan 2025
- Registered office
- 2222 Heist-op-den-Berg
- Latest accounts
- 2025 · filed on 04 May 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Sightera Biosciences (SRL) has been based in Heist-op-den-Berg since 2025, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 41,452 € and equity of 47,452 €; its revenue is not published. Its solvency stands at 74.9%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sightera Biosciences
Companies in the same business, of comparable size and area, outside its group.
- Consulting Claudine Demeyere Research and experimental development on natural sciences and engineering Dilbeek · balance sheet 66,460 €
- Dr. Frank Chielens Algemene Geneeskunde Research and experimental development on natural sciences and engineering Ypres · balance sheet 68,508 €
- Dr. Roelandt R. Health Research and experimental development on natural sciences and engineering Affligem · balance sheet 75,195 €
- TYROScreen Research and experimental development on natural sciences and engineering Herve · balance sheet 48,550 €
- Base LT Research and experimental development on natural sciences and engineering Herbeumont · balance sheet 47,144 €
- IDA International Research and experimental development on natural sciences and engineering Leuven · balance sheet 101,921 €
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Nxtlab Research and experimental development on natural sciences and engineering Roeselare · balance sheet 119,190 €
Frequently asked questions about Sightera Biosciences
What is the revenue of Sightera Biosciences?
Sightera Biosciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sightera Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE1018457141 for Sightera Biosciences, if the company is VAT-registered. Its company number (CBE) is 1018.457.141.
Where is the registered office of Sightera Biosciences?
According to the CBE register, the registered office of Sightera Biosciences is in 2222 Heist-op-den-Berg.
What is the equity of Sightera Biosciences?
At the close of the 2025 financial year, the equity of Sightera Biosciences amounts to 47,452 €, a solvency of 74.9% of total assets.
Who manages Sightera Biosciences?
The register lists 10 active mandates at Sightera Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sightera Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →